EE200300095A - Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega - Google Patents

Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega

Info

Publication number
EE200300095A
EE200300095A EEP200300095A EEP200300095A EE200300095A EE 200300095 A EE200300095 A EE 200300095A EE P200300095 A EEP200300095 A EE P200300095A EE P200300095 A EEP200300095 A EE P200300095A EE 200300095 A EE200300095 A EE 200300095A
Authority
EE
Estonia
Prior art keywords
inhibiting
agent
decrease
methods
sampling
Prior art date
Application number
EEP200300095A
Other languages
English (en)
Estonian (et)
Inventor
Lin Weiqi
J. N. Cormier Michel
E. Daddona Peter
A. Johnson Juanita
A. Matriano James
Original Assignee
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation filed Critical Alza Corporation
Publication of EE200300095A publication Critical patent/EE200300095A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
EEP200300095A 2000-09-08 2001-09-06 Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega EE200300095A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (en) 2000-09-08 2001-09-06 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure

Publications (1)

Publication Number Publication Date
EE200300095A true EE200300095A (et) 2005-02-15

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300095A EE200300095A (et) 2000-09-08 2001-09-06 Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega

Country Status (24)

Country Link
US (1) US7438926B2 (es)
EP (1) EP1335711B1 (es)
JP (2) JP5507030B2 (es)
KR (1) KR100764699B1 (es)
CN (1) CN100421653C (es)
AT (1) ATE367805T1 (es)
AU (2) AU2001288774B2 (es)
BR (1) BR0113749A (es)
CA (1) CA2422200A1 (es)
CZ (1) CZ2003687A3 (es)
DE (1) DE60129585T2 (es)
DK (1) DK1335711T3 (es)
EE (1) EE200300095A (es)
ES (1) ES2290166T3 (es)
IL (1) IL154811A0 (es)
MA (1) MA25958A1 (es)
MX (1) MXPA03002122A (es)
NO (1) NO20031071L (es)
NZ (1) NZ524646A (es)
PL (1) PL365603A1 (es)
PT (1) PT1335711E (es)
RU (1) RU2272618C2 (es)
WO (1) WO2002019985A2 (es)
ZA (1) ZA200302700B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60129585T2 (de) * 2000-09-08 2008-04-17 Alza Corp., Mountain View Transdermale vorrichtung
MXPA03003815A (es) * 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
BRPI0412029A (pt) 2003-06-30 2006-09-05 Alza Corp formulações para microprojeções revestidas contendo contra-ìons não-voláteis
US20050025778A1 (en) * 2003-07-02 2005-02-03 Cormier Michel J.N. Microprojection array immunization patch and method
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
AU2004286232A1 (en) * 2003-10-23 2005-05-12 Alza Corporation Compositions of stabilized DNA for coating microprojections
WO2005042054A2 (en) 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
EP1682012A4 (en) * 2003-11-13 2008-09-24 Alza Corp COMPOSITION AND APPARATUS FOR TRANSDERMAL DELIVERY
CA2562932A1 (en) 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
MXPA06011971A (es) * 2004-04-13 2007-04-16 Johnson & Johnson Aparato y metodo para suministro transdermico de multiples vacunas.
AU2005235075A1 (en) * 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of fentany-based agents
WO2006020841A2 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
JP5015787B2 (ja) 2004-11-18 2012-08-29 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルアレイの接触コーティング法
AU2005306426B2 (en) * 2004-11-18 2011-04-28 3M Innovative Properties Company Masking method for coating a microneedle array
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
CA2597931A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20060253079A1 (en) * 2005-04-25 2006-11-09 Mcdonough Justin Stratum corneum piercing device
WO2007002523A2 (en) 2005-06-24 2007-01-04 3M Innovative Properties Company Collapsible patch with microneedle array
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
WO2007061781A1 (en) * 2005-11-18 2007-05-31 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
CN102470118B (zh) * 2009-07-24 2014-12-17 21世纪国际新技术株式会社 含有NSAIDs的外用剂及该外用剂的制造方法
EP2818159A1 (de) * 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
CA2205444A1 (en) * 1994-12-09 1996-06-13 Novartis Ag Transdermal system
AU5740496A (en) 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
WO1996037256A1 (en) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
DE19525607A1 (de) 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
AU3399197A (en) 1996-06-18 1998-01-07 Alza Corporation Device for enhancing transdermal agent delivery or sampling
DK0921840T3 (da) 1996-07-03 2003-09-22 Altea Therapeutics Corp Multipel mekanisk mikroperforering af hud eller slimhinde
EP0934093B1 (en) 1996-09-17 2003-01-15 Deka Products Limited Partnership System for delivery of drugs by transport
DE69720057T2 (de) 1996-12-20 2003-09-25 Alza Corp Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
CA2789115C (en) * 1996-12-31 2014-04-29 Altea Therapeutics Corporation Microporation of tissue for delivery of bioactive agents
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
ATE302041T1 (de) * 1997-12-11 2005-09-15 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
EP1037687B8 (en) 1997-12-11 2008-10-22 Alza Corporation Device for enhancing transdermal agent flux
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
WO1999064580A1 (en) 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
AU771818B2 (en) * 1999-05-17 2004-04-01 Stephen T Flock Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
EP1187653B1 (en) * 1999-06-04 2010-03-31 Georgia Tech Research Corporation Devices for enhanced microneedle penetration of biological barriers
WO2001041863A1 (en) * 1999-12-10 2001-06-14 Alza Corporation Device and method for enhancing microprotrusion skin piercing
WO2001041864A1 (en) * 1999-12-10 2001-06-14 Alza Corporation Skin treatment apparatus for sustained transdermal drug delivery
DE60129585T2 (de) * 2000-09-08 2008-04-17 Alza Corp., Mountain View Transdermale vorrichtung
MXPA03003815A (es) * 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
CA2516547A1 (en) * 2002-09-30 2004-04-15 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
DE60129585D1 (de) 2007-09-06
AU2001288774B2 (en) 2006-06-29
US7438926B2 (en) 2008-10-21
JP5507030B2 (ja) 2014-05-28
MA25958A1 (fr) 2003-12-31
WO2002019985A2 (en) 2002-03-14
JP2013256500A (ja) 2013-12-26
ATE367805T1 (de) 2007-08-15
JP2004508319A (ja) 2004-03-18
RU2272618C2 (ru) 2006-03-27
CZ2003687A3 (cs) 2004-01-14
ES2290166T3 (es) 2008-02-16
ZA200302700B (en) 2004-08-13
WO2002019985A3 (en) 2002-09-06
KR20030074595A (ko) 2003-09-19
MXPA03002122A (es) 2004-09-10
DE60129585T2 (de) 2008-04-17
NO20031071L (no) 2003-05-06
EP1335711A2 (en) 2003-08-20
PL365603A1 (en) 2005-01-10
PT1335711E (pt) 2007-09-05
EP1335711B1 (en) 2007-07-25
BR0113749A (pt) 2004-06-22
CN1473037A (zh) 2004-02-04
NZ524646A (en) 2004-10-29
CA2422200A1 (en) 2002-03-14
IL154811A0 (en) 2003-10-31
CN100421653C (zh) 2008-10-01
AU8877401A (en) 2002-03-22
KR100764699B1 (ko) 2007-10-08
DK1335711T3 (da) 2007-11-26
NO20031071D0 (no) 2003-03-07
US20020102292A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
EE200300095A (et) Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega
HK1068545A1 (en) Transdermal patch for administering fentanyl
DK1178783T3 (da) Indretning og anvendelse til forögelse af den transdermale permeation af lægemidler
BR0312671A (pt) Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
WO2004006906A3 (en) Methods for the treatment of neoplasms
BR9807816A (pt) Permeação anestésica tópica assistida a laser
EA200501702A1 (ru) Устойчивая к манипуляциям дозировочная форма для трансдермального введения
CY1109070T1 (el) Διαδερμικη μορφη δοσολογιας περιλαμβανουσα ενα δραστικο παραγοντα και ενα αλας και μια μορφη ελευθερης βασεως ενος ανταγωνιστη
HUP9901991A2 (hu) Transzdermális eszköz flurbiprofén átadására
DK0764020T3 (da) Transdermalt system til indgivelse af lægemiddel
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
MXPA06001110A (es) Uso de una combinacion de un inhibidor de la cinasa del receptor del factor de crecimiento epidermico y agentes citotoxicos para el tratamiento e inhibicion del cancer.
DK1476141T3 (da) Manipulationssikrede anordninger til transdermal opioidadministration
BRPI0415986A (pt) método e aparelho para reduzir a incidência do uso de tabaco
DE60112248D1 (de) Allzweck -medikament und -wärmebehandlungssystem
WO2002049630A3 (en) Method for preventing or treating pain by administering an endothelin antagonist
HUP0200189A2 (hu) Nikotintartalmú transzdermális rendszer
WO2007143185A3 (en) Transdermal treatment of tendinopathy using glyceryl trinitrite
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
GEP201606538B (en) Preoperative treatment of post operative pain
IL141117A0 (en) Means for retaining transcutaneous catheters and needles in place
WO2001000191A3 (en) Use of fosphenytion for the treatment of acute neuropathic pain
TW200614985A (en) Compositions for the treatment of inflammation and pain using a combination of an NSAID and LTB4 receptor antagonist